90 related articles for article (PubMed ID: 19519203)
1. Molecular characterization and classification of neuroblastoma.
Oberthuer A; Theissen J; Westermann F; Hero B; Fischer M
Future Oncol; 2009 Jun; 5(5):625-39. PubMed ID: 19519203
[TBL] [Abstract][Full Text] [Related]
2. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
Øra I; Eggert A
Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
[TBL] [Abstract][Full Text] [Related]
3. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
Oberthuer A; Warnat P; Kahlert Y; Westermann F; Spitz R; Brors B; Hero B; Eils R; Schwab M; Berthold F; Fischer M
Cancer Lett; 2007 Jun; 250(2):250-67. PubMed ID: 17126996
[TBL] [Abstract][Full Text] [Related]
4. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
5. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
Deyell RJ; Attiyeh EF
Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
[TBL] [Abstract][Full Text] [Related]
6. Genetic stratification of neuroblastoma for treatment tailoring.
Jeison M; Yaniv I; Ash S
Future Oncol; 2011 Sep; 7(9):1087-99. PubMed ID: 21919696
[TBL] [Abstract][Full Text] [Related]
7. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.
Nakagawara A; Ohira M
Cancer Lett; 2004 Feb; 204(2):213-24. PubMed ID: 15013220
[TBL] [Abstract][Full Text] [Related]
9. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds.
De Preter K; De Brouwer S; Van Maerken T; Pattyn F; Schramm A; Eggert A; Vandesompele J; Speleman F
Clin Cancer Res; 2009 Jun; 15(11):3690-6. PubMed ID: 19435837
[TBL] [Abstract][Full Text] [Related]
10. Estimation of diagnostic value of chosen markers of neural differentiation in neuroblastoma group of tumors and pPNETs.
Sałacińska-Łoś E; Kobos J; Taran K
Pol J Pathol; 2008; 59(4):195-9. PubMed ID: 19391485
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma genetics and phenotype: a tale of heterogeneity.
Speleman F; De Preter K; Vandesompele J
Semin Cancer Biol; 2011 Oct; 21(4):238-44. PubMed ID: 21839839
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
[TBL] [Abstract][Full Text] [Related]
13. Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
Ohira M; Nakagawara A
Cancer Sci; 2010 Nov; 101(11):2295-301. PubMed ID: 20731666
[TBL] [Abstract][Full Text] [Related]
14. Proteomic approaches in neuroblastoma: a complementary clinical platform for the future.
Kumar HR; Zhong X; Rescorla FJ; Hickey RJ; Malkas LH; Sandoval JA
Expert Rev Proteomics; 2009 Aug; 6(4):387-94. PubMed ID: 19681674
[TBL] [Abstract][Full Text] [Related]
15. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling: decoding breast cancer.
de Snoo F; Bender R; Glas A; Rutgers E
Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
[TBL] [Abstract][Full Text] [Related]
19. New molecular classifications of breast cancer.
Cianfrocca M; Gradishar W
CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
[TBL] [Abstract][Full Text] [Related]
20. Role of molecular studies in the classification of lymphoma.
Bagg A
Expert Rev Mol Diagn; 2004 Jan; 4(1):83-97. PubMed ID: 14711352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
